MALIGNANT NEOPLASM PROGRESSION

This adverse event was reported 102511 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM PROGRESSION:

# Drug Count
0 PEMBROLIZUMAB 12384
1 NIVOLUMAB 9963
2 CARBOPLATIN 6347
3 ENZALUTAMIDE 5499
4 EVEROLIMUS 4746
5 LETROZOLE 4614
6 PACLITAXEL 4514
7 FULVESTRANT 4341
8 CAPECITABINE 4033
9 PACLITAXEL (AIBUMIN-BOUND) 3938
See all common drugs associated with MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 STREPTOZOCIN 63 0.2739
1 AFATINIB 1696 0.2561
2 GEFITINIB 1824 0.2029
3 PRALATREXATE 118 0.1815
4 CERITINIB 430 0.1804
5 BELZUTIFAN 262 0.1474
6 FULVESTRANT 4341 0.1295
7 RAMUCIRUMAB 817 0.1293
8 ZONGERTINIB 21 0.1257
9 PEMBROLIZUMAB 12384 0.1141
See all drugs enriched for association with MALIGNANT NEOPLASM PROGRESSION